ImmunityBio (IBRX) Stock
ImmunityBio (IBRX) closed at $6.70 on Nov 18, 2026; its Tenet Score is 51 of 100 against 340 Healthcare peers.
35 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Close
- $6.70
- Nov 18, 2026
- Market cap
- $6.7B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 1.95 – 12.43
- low → high · as of close, Nov 17, 2026
- Tenet Score
- 51/100
- Mixed · 340 Healthcare peers
Industry: Drugs
ImmunityBio Inc scores 51/100. Mixed. Strongest on financial health, quality is the soft spot versus 340 Healthcare peers. Insufficient inputs: Tenet 51 is built from 3 of 4 pillars, from 45% of its inputs. The pillars showing a dash had no data.
Tenet Score · vs sector
n=340Factor grades
Value omitted — no data yet.
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ✕ Quality Compounder
- ✕ Drawdown Context
- ✕ Reversal Evidence
13F flows & insider trades land here.
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators,…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 17, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Alkermes plcALKS | 37 | $7.6B |
| Twist Bioscience CorpTWST | 47 | $7.6B |
| Kiniksa Pharmaceuticals International Plc.KNSA | 55 | $7.5B |
| Amneal Pharmaceuticals IncAMRX | 39 | $7.4B |
| Cytokinetics IncCYTK | 34 | $7.2B |
| Axsome Therapeutics IncAXSM | 31 | $7.2B |
| Oruka Therapeutics Inc.ORKA | 54 | $6.5B |
| Belite Bio IncBLTE | 55 | $6.2B |
| Arrowhead Pharmaceuticals Inc.ARWR | 33 | $6.1B |
| Ligand Pharmaceuticals, Inc.LGND | 40 | $5.9B |
Common questions
What sector and industry is ImmunityBio in?
ImmunityBio is in the Healthcare sector and the Drugs industry.
What is ImmunityBio's Tenet Score?
ImmunityBio's Tenet Score is 51 out of 100, ranked against 340 Healthcare peers as of Nov 17, 2026.




